MyFinsight
Home
Blog
About
Contact
Download
Download image
Sequencing
$3,404M
(1.86%↑ Y/Y)
Microarray
$305M
(-2.87%↓ Y/Y)
Sequencing
$581M
(-10.75%↓ Y/Y)
Microarray
$53M
(-18.46%↓ Y/Y)
Product
$3,709M
(1.45%↑ Y/Y)
Service
$634M
(-11.45%↓ Y/Y)
Total revenue
$4,343M
(-0.66%↓ Y/Y)
Gross profit
$2,870M
(0.31%↑ Y/Y)
Other income
(expense), net
$340M
(216.44%↑ Y/Y)
Total cost of revenue
$1,473M
(-2.51%↓ Y/Y)
Interest income
$40M
(-13.04%↓ Y/Y)
Income (loss) from
operations
$807M
(196.88%↑ Y/Y)
Total other income
(expense), net
$279M
(180.64%↑ Y/Y)
Total operating
expense
$2,063M
(-44.15%↓ Y/Y)
Interest expense
$101M
(1.00%↑ Y/Y)
Cost of
revenue-Product
$1,107M
(8.85%↑ Y/Y)
Cost of
revenue-Service
$300M
(-18.26%↓ Y/Y)
Amortization of acquired
intangible assets
$66M
(-48.03%↓ Y/Y)
Income (loss) before
income taxes
$1,086M
(192.11%↑ Y/Y)
Selling, general and
administrative
$1,086M
(-0.55%↓ Y/Y)
Research and development
$967M
(-17.28%↓ Y/Y)
Legal contingency and
settlement
-$10M
(-102.19%↓ Y/Y)
Net income (loss)
$850M
(169.50%↑ Y/Y)
Provision for income taxes
$236M
(436.36%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ILLUMINA, INC. (ILMN)
ILLUMINA, INC. (ILMN)